Related Experiment Videos
Deep sclerectomy: results with and without collagen implant
E Sanchez1, C C Schnyder, M Sickenberg
1Hôpital Ophtalmique Jules Gonin, Department of Ophthalmology, University of Lausanne, Switzerland.
International Ophthalmology
|January 1, 1996
Summary
Collagen implants improve deep sclerectomy success rates for glaucoma patients. This safe method reduces the need for post-surgery glaucoma medications and bleb fibrosis.
Area of Science:
- Ophthalmology
- Glaucoma Surgery
- Biomaterials in Surgery
Background:
- Open-angle glaucoma requires effective surgical interventions to manage intraocular pressure (IOP).
- Deep sclerectomy is a non-penetrating filtration procedure for glaucoma, with varying success rates.
- Collagen implants are being explored to enhance surgical outcomes in glaucoma treatment.
Purpose of the Study:
- To evaluate the safety and efficacy of using a collagen implant in conjunction with deep sclerectomy.
- To compare the success rates and clinical outcomes of deep sclerectomy with collagen implant (DSCI) versus deep sclerectomy alone (DS).
Main Methods:
- A prospective study involving 168 patients with medically uncontrolled open-angle glaucoma.
- 86 patients underwent DSCI, and 82 underwent DS, with follow-up extending to 24 months.
- Key metrics included visual acuity, IOP, medication use, and bleb fibrosis, assessed pre- and post-operatively.
Main Results:
- DSCI demonstrated significantly higher complete and qualified success rates compared to DS.
- Patients receiving DSCI required fewer postoperative glaucoma medications (0.2 vs. 0.5 per patient).
- Bleb fibrosis was significantly reduced in the DSCI group (2% vs. 11%).
Conclusions:
- The collagen implant is a safe addition to deep sclerectomy, enhancing surgical success.
- Utilizing a collagen implant reduces the need for long-term glaucoma medication.
- Collagen implants appear to mitigate bleb fibrosis, a common complication in glaucoma surgery.